- Home
- STOK vs ATRO Comparison
STOK vs ATRO Comparison
Compare STOK & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- ATRO
- Stock Information
- Founded
- STOK 2014
- ATRO 1968
- Country
- STOK United States
- ATRO United States
- Employees
- STOK N/A
- ATRO N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- ATRO Military/Government/Technical
- Sector
- STOK Health Care
- ATRO Industrials
- Exchange
- STOK Nasdaq
- ATRO Nasdaq
- Market Cap
- STOK 721.4M
- ATRO 592.4M
- IPO Year
- STOK 2019
- ATRO N/A
- Fundamental
- Price
- STOK $9.36
- ATRO $16.91
- Analyst Decision
- STOK Strong Buy
- ATRO Hold
- Analyst Count
- STOK 8
- ATRO 1
- Target Price
- STOK $21.83
- ATRO $17.00
- AVG Volume (30 Days)
- STOK 933.4K
- ATRO 282.9K
- Earning Date
- STOK 11-05-2024
- ATRO 02-26-2025
- Dividend Yield
- STOK N/A
- ATRO N/A
- EPS Growth
- STOK N/A
- ATRO N/A
- EPS
- STOK N/A
- ATRO N/A
- Revenue
- STOK $16,742,999.00
- ATRO $782,178,000.00
- Revenue This Year
- STOK $105.42
- ATRO $15.70
- Revenue Next Year
- STOK N/A
- ATRO $6.98
- P/E Ratio
- STOK N/A
- ATRO N/A
- Revenue Growth
- STOK 81.08
- ATRO 19.95
- 52 Week Low
- STOK $4.09
- ATRO $14.13
- 52 Week High
- STOK $17.58
- ATRO $23.74
- Technical
- Relative Strength Index (RSI)
- STOK 36.22
- ATRO 58.88
- Support Level
- STOK $8.42
- ATRO $15.56
- Resistance Level
- STOK $9.77
- ATRO $17.10
- Average True Range (ATR)
- STOK 0.66
- ATRO 0.55
- MACD
- STOK -0.09
- ATRO 0.17
- Stochastic Oscillator
- STOK 28.40
- ATRO 88.62
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.